[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"breath-holding-attack\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:breath-holding-attack":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100359891","phase-3-docosahexaenoic-acid-on-breath-holding-spells-in-children-100359891",false,"NCT03965988","Docosahexaenoic Acid on Breath Holding Spells in Children","Effect of Docosahexaenoic Acid on Breath Holding Spells in Children: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Children with newly diagnosed sprlls\n\nExclusion Criteria Other treatment as iron and piracetam","ALL","1 Month","5 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"PHASE3","DHA on Breath Holding Spells",[27],"Breath Holding Attack","RECRUITING","2019-05-24",{"date":31,"type":32},"2019-05-29","ACTUAL",{"date":34,"type":32},"2018-05-01",{"date":36,"type":21},"2028-12",{"name":38,"class":39},"Sherief Abd-Elsalam","OTHER"]